Prospective study of eukaryotic initiation factor 4E protein elevation and breast cancer outcome

Annals of Surgery

Volumn 235, Issue 5, 2002, Pages 732-739

  Li, Benjamin D L ^a,e   Gruner, Jeffrey S ^a   Abreo, Fleurette ^a   Johnson, Lester W ^c   Yu, Herbert ^d   Nawas, Soheir ^c   McDonald, John C ^a   DeBenedetti, Arrigo ^b  

^a Louisiana State University School of Medicine Shreveport   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c EA Conway Hospital   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; INITIATION FACTOR 4E; MESSENGER RNA; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN SYNTHESIS; TUMOR VOLUME;

BLOTTING, WESTERN; BREAST NEOPLASMS; EUKARYOTIC INITIATION FACTOR-4E; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PEPTIDE INITIATION FACTORS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0036236341     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-200205000-00016     Document Type: Article

References (32)

1. Pathologic prognostic factors for patients with breast carcinoma: Which factors are important
2. Predicting axillary nodal positivity in 2282 patients with breast carcinoma
3. Significance of axillary lymph node metastasis in primary breast cancer
4. EIF4E expression in tumors: Its possible role in progression of malignancies
5. Mechanism of action and regulation of protein synthesis initiation factor 4E: Effects of mRNA discrimination, cellular growth rate, and oncogenesis
6. mRNA 5′ cap-binding protein eIF4E and control of cell growth
7. Essentials of signal transduction
8. Essentials of molecular biology: Basic principles
9. Molecular biology of cancer: The cell cycle
10. Elevated levels of cyclin D1 in response to increased expression of eukaryotic initiation factor 4E
11. Overproduction of ornithine decarboxylase caused by relief of translational repression is associated with neoplastic transformation
12. Overexpression of eukaryotic protein synthesis initiation factor 4E in HeLa cells results in aberrant growth and morphology
13. Overexpression of the protooncogene/translation factor 4E in breast carcinoma cell lines
14. Detection of the proto-oncogene eIF4E in surgical margins may predict recurrence in head and neck cancer
15. Overexpression of eukaryotic initiation factor 4E (eIF4E) in breast carcinoma
16. Expression of antisense RNA against initiation factor eIF4E mRNA in HeLa cells results in lengthened cell division times, diminished translation rates, and reduced levels of both eIF4E and p220 components of eIF4F
17. CHO cells transformed by the translation factor eIF4E display increased c-myc expression, but require overexpression of max for tumorigenicity
18. Translational enhancement of FGF-2 by eIF4E factors, and alternate utilization of CUG and AUG codons for translation initiation
19. Translational regulation of vascular permeability factor by eukaryotic initiation factor 4E: Implications for tumor angiogenesis
20. A translationally regulated Tousled kinase phosphorylates histone H3 and confers radioresistance when overexpressed
21. Decreasing the level of translation initiation factor 4E with antisense RNA causes reversal of tax-mediated transformation and tumorigenesis of cloned rat embryo fibroblasts
22. The proto-oncogene/translation factor eIF4E: A survey of its expression in breast carcinomas
23. Clinical outcome in stage I to III breast carcinoma and eIF4E overexpression
24. The role of observational studies in the evaluation of therapy
25. Why databases should not replace randomized clinical trials
26. Analysis of surgical margins with the molecular marker eIF4E: A prognostic factor in patients with head and neck cancer
27. Epithelial cells in bone marrow of breast cancer patients at time of primary surgery: Clinical outcome during long-term follow-up
28. Vascular endothelial growth factor and platelet-derived endothelial cell growth factor are frequently coexpressed in highly vascularized human breast cancer
29. Vascular endothelial growth factor and platelet-derived growth factor are potential angiogenic and metastatic factors human breast cancer
30. Vascular endothelial growth factor (VEGF) in human breast cancer: Correlation with disease-free survival
31. Tumor angiogenesis and metastasis: Correlation in invasive breast carcinoma
32. The prognostic value of angiogenesis by Chalkley counting in a confirmatory design on 836 breast cancer patients